OncLive® Presents a Webinar on Treatment of Hepatocellular Carcinoma

OncLive, the nations leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host the live webinar, A Practical Approach to Treatment of Hepatocellular Carcinoma on March 21, at 3 p.m. (EDT).

We look forward to presenting this webinar that will provide insight on hepatocellular carcinoma, said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of OncLive. Attendees will gain insights from two experts discussing current trends in the HCC space.

Presenters for this webinar include:

  • Anthony El-Khoueiry, M.D., assistant professor of clinical medicine at the Keck School of Medicine of the University of Southern California and director of clinical translation at the Southern California Clinical and Translational Science Institute
  • Richard Finn, M.D., assistant professor of medicine at the Geffen School of Medicine at the University of California, Los Angeles.

Designed for oncologists, physicians and health care professionals interested in learning about treatment of HCC, the webinar will discuss implications of recent clinical trial data and discuss current trends and treatments for HCC.

For more information and to register, click here.

About OncLive

The most comprehensive portal for practicing oncologists, OncLive presents information oncologists can use to provide the best patient care, including articles, blogs, live coverage from major oncology meetings and more. OncLive is the official website for the Cranbury, New Jersey-based MJH Associates Inc. Oncology Specialty Group, which publishes OncologyLive, Oncology Nursing News and more. Home to the Peer Exchange and Insights video editorial series, OncLive provides a unique opportunity for oncologists to view lively discussions with opinions and perspectives on issues facing cancer care professionals.

ALSO READ:   AVROBIO, Inc. Announces Acceptance of Investigational New Drug (IND) Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis

OncLive® Media
Theresa Burek, 609-250-4331
[email protected]

John Patricolo, 609-325-4630
[email protected]